When Onward was first diagnosed with chronic myeloid leukemia (CML), he spent many sleepless nights thinking about his future. Now, 11 years later, he advocates and provides support for other people going through the same thing.
“I am now living a normal life and enjoying my cycling, and gardening, and forgetting about CML, I only remember that I am a patient when it’s time to take my medication,” he said. “I now have hope, and I am able to instill hope to newly diagnosed patients.”
Onward is a 45-year-old farmer living in Zimbabwe with his wife, Tabeth, and their four children. In 2014, he started feeling weak and losing weight, and noticed he couldn’t cycle as far.
Onward said it took a while to be diagnosed then because the blood samples had to be taken to South Africa. He also had to sell his only car and furniture to afford the tests. Finally, a doctor confirmed that he had CML.
“My wife was so young at that stage, and I was just jealous and scared of losing her to someone else or not being able to grow old with her,” he said. “It wasn’t easy to accept.”
The doctor said medication was expensive, so he recommended our program. The Max Foundation and its partners provide access to treatment free of charge. After treatment, Onward started feeling better. He said every time he went for a checkup, there was good news.
In 2015, after encouragement from a Max team member, Onward became one of four founding members of the CML Zimbabwe Trust. They provide support, comfort, and education for patients. Currently, they’re letting people know about the transportation grants from Max to motivate them to seek treatment.
“I would like to thank the Max Foundation for the donation of the medication, which saves hundreds of patients in my country,” Onward said.
In 2022, Onward and Tabeth welcomed their fourth child, a son. Although he lost sleep over his diagnosis, Onward said he’s now proud to share his story and pass hope along to others.
The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 28 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.
Related Articles
Un Paso Max: Going the Extra Mile in the Dominican Republic
Un Paso Max, meaning “Un Paso Mas” (One More Step) is a fitting name for a group led by cancer survivors who are willing to take an extra step to help others. Un Paso Max is the name of the CML and GIST patient association in the Dominican Republic. One can trace the origins of this group to a small meeting in 2008. It only took a bit of encouragement and support on the part of The Max Foundation to unlock the passion of a handful of courageous survivors in Santo Domingo, and the seed of a patient association was planted.
Light a Candle on March 9th to Honor Max
March 9th marks a somber anniversary; the day Max lost his 3 year battle with chronic myeloid leukemia (CML). For those of us who love Max, who either knew him then or who know and love him now, this will always be a day of sorrow. The words that come to mind are words such as ugly, unfair, impossible, and the feeling is one of emptiness; a whole in one’s heart. Max was a real person, a beautiful young child, whose encounter with cancer was nothing but a tragic episode.
Shining a Light on Sandra’s Resilience
People living with cancer deserve access to holistic treatment, including support, education, and the opportunity to connect with others in a similar situation. That’s why The Max Foundation and its partners offer more than just medicine. Sandra from Chile started participating in our treatment adherence program, Day by Day, after being diagnosed with chronic myeloid….
The Max Foundation uses cookies to improve your experience on our site. Please read our Privacy Policy for more information.